Journal of Dermatological Treatment · 2019 · 37 citations · 16 references
MedicineDermatologyPharmacotherapyDermatologic SurgeryDermatopathologyImmunotherapyBotulinum Toxin TherapyBotulinum Toxin TreatmentToxin-mediated DiseaseBotulinum Toxin DosageKeloid Scar ManagementKeloid ScarringKeloid SurgeryKeloid TreatmentSurface AreaSurface Area QuantificationTherapeutic Toxin Applications
Objective: Despite the myriad options available, there is no universally the accepted treatment for keloids. Our objective was to compare three regiments and establish superiority in terms of objective and subjective outcomes.Approach: In this intervention study, 50 patients were enrolled. The Group I: included 26 patients with at least two keloid lesions subjected to intralesional triamcinolone acetonide in left-sided lesions and intralesional botulinum toxin type A in right-sided lesions. While group II included 24 patients subjected to a combination of both intralesional TAC and BTX-A. Injections were done for a total of three sessions 4 weeks apart. Color Doppler ultrasound (CDU) was done before and one month after treatment.Results: In terms of thickness and surface area the keloids responded significantly better to combined TCA and BTX versus TCA alone or BTX alone (p .0001). Also improvement in transverse and longitudinal axis was significantly higher in combined therapy (p < .0001 and .004, respectively). Conclusion: Combined injection of intralesional steroids with BTX-A appears to be superior to either therapy alone and offer the best benefit of safer and more efficacious response with lesser side effects.
16
Keloids: Pathophysiology and management
David T. Robles, Erin Moore, Michelle Draznin et al. · Dermatology Online Journal · 2007 · 247 citations · Full text
Medicine, Dermatology, Pathology +17
Eman Shaarawy, Rehab A. Hegazy, Rania Abdel Hay · Journal of Cosmetic Dermatology · 2015 · 141 citations